Annie Chang, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chang’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A153415 · Current
Licensed to practise in California · since 2018 · expires 2028-01-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$458,371 in 2024
Medicaid paid $458,371 for 8,260 billed services this clinician did in 2024, up to 122 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,376 | $457,327 |
| Short return visit (20+ min) | 1,295 | $671 |
| Return visit (30+ min) | 714 | $373 |
| Pain severity quantified; pain present (COA) (ONC) | 275 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 313 | $0 |
| Medication list documented in medical record (COA) | 772 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 72 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 836 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 360 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 511 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 646 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 527 | $0 |
| 2024 | 8,260 | 14 | 122 | $458,371 |
| 2023 | 4,055 | 11 | 130 | $373,864 |
| 2022 | 4,032 | 10 | 121 | $332,253 |
| 2021 | 4,616 | 10 | 110 | $495,442 |
| 2020 | 2,994 | 4 | 123 | $361,509 |
| 2019 | 635 | 4 | 93 | $53,087 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,185 | $373,234 |
| Short return visit (20+ min) | 1,864 | $620 |
| Smoking and tobacco use cessation counseling visit; intermediate, greater than 3 minutes up to 10 minutes | 21 | $10 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 207 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 190 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 62 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 126 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 139 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 113 | $0 |
| Most recent diastolic blood pressure greater than or equal to 90 mm Hg (HTN, CKD, CAD) (DM) | 126 | $0 |
| Return visit (30+ min) | 22 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 1,039 | $329,138 |
| Short return visit (20+ min) | 1,738 | $3,104 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 48 | $10 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 256 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 217 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 86 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 158 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 175 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 187 | $0 |
| Most recent diastolic blood pressure greater than or equal to 90 mm Hg (HTN, CKD, CAD) (DM) | 128 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 1,470 | $493,814 |
| Short return visit (20+ min) | 2,331 | $1,628 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 179 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 149 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 60 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 106 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 126 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 112 | $0 |
| Most recent diastolic blood pressure greater than or equal to 90 mm Hg (HTN, CKD, CAD) (DM) | 59 | $0 |
| Blood glucose (sugar) level | 24 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 1,205 | $360,471 |
| Short return visit (20+ min) | 1,722 | $747 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 30 | $291 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 37 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 176 | $52,798 |
| Short return visit (20+ min) | 414 | $281 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 26 | $4 |
| Blood glucose (sugar) level | 19 | $3 |
Drugs they prescribed that Part D paid
$168,389
Pharmacies billed $168,389 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (51 of 1,017) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%. Long-acting opioids: 61% of their opioid prescriptions.
782 generic and fewer than 11 brand-name prescriptions · $168,389 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 21 | $20,698 | $986 |
| Mounjaro | 14 | $14,207 | $1,015 |
| Trulicity | 16 | $13,841 | $865 |
| Jardiance | 20 | $12,714 | $636 |
| Eliquis | 11 | $10,244 | $931 |
See all 27 drugs
| Ozempic | 21 | $20,698 | $986 |
| Mounjaro | 14 | $14,207 | $1,015 |
| Trulicity | 16 | $13,841 | $865 |
| Jardiance | 20 | $12,714 | $636 |
| Eliquis | 11 | $10,244 | $931 |
| Buprenorphine-Naloxone | 41 | $8,352 | $204 |
| Synjardy Xr | 11 | $5,915 | $538 |
| Buprenorphine | 12 | $2,388 | $199 |
| Gabapentin | 54 | $619 | $11 |
| Albuterol Sulfate Hfa | 15 | $522 | $35 |
| Atorvastatin | 69 | $304 | $4 |
| Amiodarone | 12 | $252 | $21 |
| Pregabalin | 23 | $171 | $7 |
| Morphine Sulfate Er | 13 | $156 | $12 |
| Metoprolol | 23 | $118 | $5 |
| Fluticasone Propionate | 17 | $117 | $7 |
| Tamsulosin | 21 | $110 | $5 |
| Amlodipine Besylate | 41 | $75 | $2 |
| Metformin | 18 | $65 | $4 |
| Lisinopril | 31 | $52 | $2 |
| Triamcinolone Acetonide | 12 | $49 | $4 |
| Sertraline | 15 | $39 | $3 |
| Hydrocodone-Acetaminophen | 11 | $31 | $3 |
| Ibuprofen | 15 | $25 | $2 |
| Allopurinol | 11 | $23 | $2 |
| Losartan | 11 | $22 | $2 |
| Cyclobenzaprine | 12 | $16 | $1 |
Year by year
| 2024 | 1,017 | 107 | 5% (51) | None | $168,389 |
| 2023 | 891 | 116 | 8% (72) | None | $142,591 |
| 2022 | 716 | 97 | 6% (41) | None | $114,959 |
| 2021 | 660 | 109 | 3% (22) | None | $54,755 |
| 2020 | 765 | 115 | 4% (27) | None | $67,743 |
| 2019 | 415 | 78 | 5% (22) | None | $29,048 |
| 2018 | 346 | 58 | 0% (0) | None | $23,983 |
| 2017 | 441 | 52 | 0% (0) | None | $53,238 |
| 2016 | 98 | 14 | 0% (0) | None | $5,375 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 25 drugs
| Xifaxan | 12 | $36,456 | $3,038 |
| Belbuca | 12 | $11,554 | $963 |
| Trulicity | 11 | $10,517 | $956 |
| Synjardy Xr | 15 | $9,156 | $610 |
| Jardiance | 11 | $6,370 | $579 |
| Naloxone | 23 | $1,943 | $84 |
| Atorvastatin | 84 | $1,000 | $12 |
| Albuterol Sulfate Hfa | 19 | $831 | $44 |
| Levetiracetam | 14 | $747 | $53 |
| Pregabalin | 25 | $700 | $28 |
| Lisinopril | 34 | $455 | $13 |
| Oxycodone | 25 | $454 | $18 |
| Gabapentin | 25 | $395 | $16 |
| Amlodipine Besylate | 44 | $247 | $6 |
| Levothyroxine | 13 | $225 | $17 |
| Trazodone | 20 | $211 | $11 |
| Metoprolol | 32 | $167 | $5 |
| Isosorbide Mononitrate Er | 14 | $154 | $11 |
| Ibuprofen | 23 | $143 | $6 |
| Omeprazole | 13 | $136 | $10 |
| Metformin | 12 | $122 | $10 |
| Cyclobenzaprine | 13 | $121 | $9 |
| Bupropion Xl | 14 | $113 | $8 |
| Morphine Sulfate Er | 13 | $79 | $6 |
| Hydrochlorothiazide | 18 | $33 | $2 |
2022: 17 drugs
| Xarelto | 15 | $11,112 | $741 |
| Synjardy Xr | 20 | $10,389 | $519 |
| Naloxone | 16 | $1,545 | $97 |
| Albuterol Sulfate Hfa | 11 | $492 | $45 |
| Atorvastatin | 51 | $425 | $8 |
| Oxycodone | 19 | $334 | $18 |
| Tamsulosin | 14 | $253 | $18 |
| Omeprazole | 18 | $200 | $11 |
| Amlodipine Besylate | 41 | $169 | $4 |
| Cyclobenzaprine | 12 | $165 | $14 |
| Metoprolol | 18 | $124 | $7 |
| Pantoprazole | 12 | $117 | $10 |
| Famotidine | 11 | $114 | $10 |
| Isosorbide Mononitrate Er | 11 | $103 | $9 |
| Lisinopril | 12 | $90 | $7 |
| Metformin | 14 | $48 | $3 |
| Hydrochlorothiazide | 11 | $44 | $4 |
2021: 18 drugs
| Narcan | 14 | $1,707 | $122 |
| Albuterol Sulfate Hfa | 15 | $681 | $45 |
| Baclofen | 21 | $512 | $24 |
| Atorvastatin | 52 | $366 | $7 |
| Levothyroxine | 12 | $130 | $11 |
| Pantoprazole | 14 | $125 | $9 |
| Tamsulosin | 17 | $114 | $7 |
| Allopurinol | 11 | $111 | $10 |
| Gabapentin | 19 | $107 | $6 |
| Metoprolol | 11 | $102 | $9 |
| Amlodipine Besylate | 30 | $96 | $3 |
| Finasteride | 11 | $87 | $8 |
| Losartan | 16 | $82 | $5 |
| Metformin | 20 | $60 | $3 |
| Furosemide | 13 | $59 | $5 |
| Ibuprofen | 11 | $53 | $5 |
| Lisinopril | 22 | $52 | $2 |
| Sertraline | 11 | $45 | $4 |
2020: 18 drugs
| Buprenorphine-Naloxone | 12 | $1,880 | $157 |
| Ventolin Hfa | 19 | $1,051 | $55 |
| Albuterol Sulfate Hfa | 18 | $841 | $47 |
| Gabapentin | 23 | $316 | $14 |
| Atorvastatin | 50 | $264 | $5 |
| Metoprolol | 18 | $227 | $13 |
| Baclofen | 14 | $222 | $16 |
| Levothyroxine | 14 | $176 | $13 |
| Pravastatin | 17 | $170 | $10 |
| Losartan | 19 | $145 | $8 |
| Fluticasone Propionate | 11 | $116 | $11 |
| Lisinopril | 38 | $95 | $3 |
| Furosemide | 30 | $79 | $3 |
| Omeprazole | 15 | $78 | $5 |
| Metformin | 17 | $59 | $3 |
| Paroxetine | 13 | $56 | $4 |
| Amitriptyline | 11 | $56 | $5 |
| Amlodipine Besylate | 20 | $53 | $3 |
2019: 6 drugs
| Atorvastatin | 23 | $446 | $19 |
| Gabapentin | 20 | $323 | $16 |
| Lisinopril | 26 | $179 | $7 |
| Losartan | 18 | $150 | $8 |
| Omeprazole | 17 | $147 | $9 |
| Amlodipine Besylate | 13 | $64 | $5 |
2018: 8 drugs
| Atorvastatin | 23 | $535 | $23 |
| Gabapentin | 12 | $241 | $20 |
| Losartan | 17 | $160 | $9 |
| Amlodipine Besylate | 14 | $149 | $11 |
| Omeprazole | 18 | $144 | $8 |
| Metformin | 26 | $109 | $4 |
| Atenolol | 13 | $87 | $7 |
| Lisinopril | 19 | $69 | $4 |
2017: 10 drugs
| Lantus Solostar | 17 | $5,343 | $314 |
| Gabapentin | 17 | $323 | $19 |
| Atorvastatin | 20 | $283 | $14 |
| Spironolactone | 14 | $137 | $10 |
| Lisinopril | 37 | $99 | $3 |
| Pantoprazole | 12 | $92 | $8 |
| Metformin | 25 | $73 | $3 |
| Furosemide | 21 | $62 | $3 |
| Carvedilol | 12 | $44 | $4 |
| Atenolol | 13 | $29 | $2 |
Money from drug and device companies
$16 in 2025
| 2025 | 1 | 1 | None | $16 |
| 2019 | 1 | 1 | None | $116 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Mallinckrodt Hospital Products | Acthar | $16 | 1 payment
|
See the published payment
| Mallinckrodt Hospital Products | Meals · 2025-03-24 | Acthar | $16 |
See earlier years (2019)
2019: $116
| ViiV Healthcare | Dovato | $116 | 1 payment
|
Professional record
- NPI
- 1396191995
- Licence
- CA A153415California A153415: Current · expires 2028-01-31
- Trained
- University of California, San Francisco School of Medicine, 2015
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X); Student in a training program (390200000X)
- Mailing address
- 3291 Loma Vista Rd, Ventura, CA, 93003
- NPI first listed
- 2016-05-12
- NPI last updated
- 2019-05-03
This is when the NPI record was last certified, not a medical board exam.